HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High frequency of c-Met expression in gastric cancers producing alpha- fetoprotein.

Abstract
Gastric cancers producing alpha-fetoprotein (AFP) have a poor prognosis and a high incidence of liver metastasis. Hepatocyte growth factor (HGF) and its receptor, c-Met, are known to induce mitosis and cell movement and to promote tumor progression. In the present study, c-Met and HGF expression in AFP-producing gastric cancer was compared with those gastric cancers that do not produce AFP. Twenty-six patients with AFP-producing gastric cancers [AFP(+)] and 26 patients stage-matched gastric cancers without AFP production [AFP(-)] were evaluated for c-Met and HGF expression and proliferating cell nuclear antigen-labelling index using immunohistochemical analysis. A higher frequency of c-Met expression was observed in the AFP(+) group than in the AFP(-) group (p < 0.01). A higher expression of c-Met might be one explanation for the poorer prognosis of AFP-producing gastric cancers.
AuthorsH Amemiya, K Kono, Y Mori, A Takahashi, F Ichihara, H Iizuka, T Sekikawa, Y Matsumoto
JournalOncology (Oncology) Vol. 59 Issue 2 Pg. 145-51 (Aug 2000) ISSN: 0030-2414 [Print] Switzerland
PMID10971174 (Publication Type: Journal Article)
CopyrightCopyright 2000 S. Karger AG, Basel.
Chemical References
  • Proliferating Cell Nuclear Antigen
  • alpha-Fetoproteins
  • Hepatocyte Growth Factor
  • Proto-Oncogene Proteins c-met
Topics
  • Adult
  • Aged
  • Cell Division
  • Female
  • Hepatocyte Growth Factor (biosynthesis)
  • Humans
  • Male
  • Middle Aged
  • Proliferating Cell Nuclear Antigen (analysis)
  • Proto-Oncogene Proteins c-met (biosynthesis)
  • Stomach Neoplasms (metabolism)
  • Tumor Cells, Cultured
  • alpha-Fetoproteins (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: